IENAX | VENAX | IENAX / VENAX | |
Total Expense Ratio | 1.27 | 0.09 | 1,411% |
Annual Report Gross Expense Ratio | 1.27 | 0.09 | 1,411% |
Fund Existence | 24 years | 21 years | - |
Gain YTD | 11.208 | 7.037 | 159% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 432M | 9B | 5% |
Annual Yield % from dividends | 3.63 | 3.07 | 118% |
Returns for 1 year | 13.17 | 7.79 | 169% |
Returns for 3 years | 45.25 | 32.81 | 138% |
Returns for 5 years | 258.34 | 220.70 | 117% |
Returns for 10 years | 56.38 | 57.21 | 99% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
WDNA | 15.37 | 0.22 | +1.48% |
WisdomTree BioRevolution ETF | |||
WOMN | 40.77 | 0.32 | +0.79% |
Impact Shares Women’s Empowerment ETF | |||
HAWX | 37.55 | 0.06 | +0.17% |
iShares Currency Hdgd MSCI ACWI exUS ETF | |||
IPB | 26.19 | 0.01 | +0.04% |
Merrill Lynch Depositor | |||
FPF | 19.29 | -0.21 | -1.08% |
FIRST TRUST INTERMEDIATE DURATION PREFERRED & Income FUND |